295 related articles for article (PubMed ID: 12115148)
1. Alzheimer beta-amyloid peptides: structures of amyloid fibrils and alternate aggregation products.
Gorman PM; Chakrabartty A
Biopolymers; 2001; 60(5):381-94. PubMed ID: 12115148
[TBL] [Abstract][Full Text] [Related]
2. Assembling amyloid fibrils from designed structures containing a significant amyloid beta-peptide fragment.
Tjernberg LO; Tjernberg A; Bark N; Shi Y; Ruzsicska BP; Bu Z; Thyberg J; Callaway DJ
Biochem J; 2002 Aug; 366(Pt 1):343-51. PubMed ID: 12023906
[TBL] [Abstract][Full Text] [Related]
3. Peptide and protein mimetics inhibiting amyloid beta-peptide aggregation.
Takahashi T; Mihara H
Acc Chem Res; 2008 Oct; 41(10):1309-18. PubMed ID: 18937396
[TBL] [Abstract][Full Text] [Related]
4. Assembly of Alzheimer's amyloid-beta fibrils and approaches for therapeutic intervention.
Yang DS; Serpell LC; Yip CM; McLaurin J; Chrishti MA; Horne P; Boudreau L; Kisilevsky R; Westaway D; Fraser PE
Amyloid; 2001 Jul; 8 Suppl 1():10-9. PubMed ID: 11676284
[TBL] [Abstract][Full Text] [Related]
5. Zinc-amyloid beta interactions on a millisecond time-scale stabilize non-fibrillar Alzheimer-related species.
Noy D; Solomonov I; Sinkevich O; Arad T; Kjaer K; Sagi I
J Am Chem Soc; 2008 Jan; 130(4):1376-83. PubMed ID: 18179213
[TBL] [Abstract][Full Text] [Related]
6. Structure of beta-amyloid fibrils and its relevance to their neurotoxicity: implications for the pathogenesis of Alzheimer's disease.
Irie K; Murakami K; Masuda Y; Morimoto A; Ohigashi H; Ohashi R; Takegoshi K; Nagao M; Shimizu T; Shirasawa T
J Biosci Bioeng; 2005 May; 99(5):437-47. PubMed ID: 16233815
[TBL] [Abstract][Full Text] [Related]
7. Structures for amyloid fibrils.
Makin OS; Serpell LC
FEBS J; 2005 Dec; 272(23):5950-61. PubMed ID: 16302960
[TBL] [Abstract][Full Text] [Related]
8. Activation barriers to structural transition determine deposition rates of Alzheimer's disease a beta amyloid.
Esler WP; Felix AM; Stimson ER; Lachenmann MJ; Ghilardi JR; Lu YA; Vinters HV; Mantyh PW; Lee JP; Maggio JE
J Struct Biol; 2000 Jun; 130(2-3):174-83. PubMed ID: 10940224
[TBL] [Abstract][Full Text] [Related]
9. Contrasting in vivo effects of two peptide-based amyloid-beta protein aggregation inhibitors in a transgenic mouse model of amyloid deposition.
Li Q; Gordon M; Etienne MA; Hammer RP; Morgan D
Cell Transplant; 2008; 17(4):397-408. PubMed ID: 18522242
[TBL] [Abstract][Full Text] [Related]
10. Conformation and fibrillogenesis of Alzheimer A beta peptides with selected substitution of charged residues.
Fraser PE; McLachlan DR; Surewicz WK; Mizzen CA; Snow AD; Nguyen JT; Kirschner DA
J Mol Biol; 1994 Nov; 244(1):64-73. PubMed ID: 7966323
[TBL] [Abstract][Full Text] [Related]
11. Deposition of mouse amyloid beta in human APP/PS1 double and single AD model transgenic mice.
van Groen T; Kiliaan AJ; Kadish I
Neurobiol Dis; 2006 Sep; 23(3):653-62. PubMed ID: 16829076
[TBL] [Abstract][Full Text] [Related]
12. High sensitivity analysis of amyloid-beta peptide composition in amyloid deposits from human and PS2APP mouse brain.
Güntert A; Döbeli H; Bohrmann B
Neuroscience; 2006 Dec; 143(2):461-75. PubMed ID: 17008022
[TBL] [Abstract][Full Text] [Related]
13. Structure and morphology of the Alzheimer's amyloid fibril.
Stromer T; Serpell LC
Microsc Res Tech; 2005 Jul; 67(3-4):210-7. PubMed ID: 16103997
[TBL] [Abstract][Full Text] [Related]
14. Identification and characterization of key kinetic intermediates in amyloid beta-protein fibrillogenesis.
Kirkitadze MD; Condron MM; Teplow DB
J Mol Biol; 2001 Oct; 312(5):1103-19. PubMed ID: 11580253
[TBL] [Abstract][Full Text] [Related]
15. Imaging distinct conformational states of amyloid-beta fibrils in Alzheimer's disease using novel luminescent probes.
Nilsson KP; Aslund A; Berg I; Nyström S; Konradsson P; Herland A; Inganäs O; Stabo-Eeg F; Lindgren M; Westermark GT; Lannfelt L; Nilsson LN; Hammarström P
ACS Chem Biol; 2007 Aug; 2(8):553-60. PubMed ID: 17672509
[TBL] [Abstract][Full Text] [Related]
16. A highly insoluble state of Abeta similar to that of Alzheimer's disease brain is found in Arctic APP transgenic mice.
Philipson O; Hammarström P; Nilsson KP; Portelius E; Olofsson T; Ingelsson M; Hyman BT; Blennow K; Lannfelt L; Kalimo H; Nilsson LN
Neurobiol Aging; 2009 Sep; 30(9):1393-405. PubMed ID: 18192084
[TBL] [Abstract][Full Text] [Related]
17. An autocatalytic reaction as a model for the kinetics of the aggregation of beta-amyloid.
Sabaté R; Gallardo M; Estelrich J
Biopolymers; 2003; 71(2):190-5. PubMed ID: 12767118
[TBL] [Abstract][Full Text] [Related]
18. Protein denaturation and aggregation: Cellular responses to denatured and aggregated proteins.
Meredith SC
Ann N Y Acad Sci; 2005 Dec; 1066():181-221. PubMed ID: 16533927
[TBL] [Abstract][Full Text] [Related]
19. Humoral immune response to fibrillar beta-amyloid peptide.
Miller DL; Currie JR; Mehta PD; Potempska A; Hwang YW; Wegiel J
Biochemistry; 2003 Oct; 42(40):11682-92. PubMed ID: 14529278
[TBL] [Abstract][Full Text] [Related]
20. Molecular mechanisms initiating amyloid beta-fibril formation in Alzheimer's disease.
Kirkitadze MD; Kowalska A
Acta Biochim Pol; 2005; 52(2):417-23. PubMed ID: 15933761
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]